Physician profile
Nirali R Doshi
NPI 1659664969
$1,972.71
in general payments reported to CMS, 2019-2025
20 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.65 · 2021: $46.46 · 2022: $508 · 2023: $798 · 2024: $342 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $865.32 | 2022-2024 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbott Laboratories | $336.93 | 2019-2025 | Proclaim |
| Pfizer INC. | $181.58 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $92.60 | 2022-2024 | Bridion |
| Collegium Pharmaceutical, INC. | $85.26 | 2023-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.07 | 2024-2025 | Relistor, Trulance |
| Abbvie INC. | $45.67 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.31 | 2022 | |
| Nevro Corp. | $32.21 | 2024 | Senza |
| Si-Bone, INC. | $31.61 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $26.54 | 2022 | |
| Vertos Medical, INC. | $25.00 | 2024 | Mild Device Kit |
| Grt US Holding, INC. | $23.66 | 2021 | |
| Depuy Synthes Sales INC. | $22.80 | 2021 | |
| Medtronic, INC. | $20.58 | 2023 | Intellis Adaptivestim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $19.15 | 2025 | |
| Painteq LLC | $18.62 | 2023 | Painteq |
| Idorsia Pharmaceuticals US INC | $16.97 | 2023 | Quviviq |
| Lilly USA, LLC | $15.18 | 2023 | Emgality, Reyvow |
| Medtronic USA, INC. | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirali Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.